Apellis Pharmaceuticals, Inc. (APLS)
$41.03+0.00%Close
BUYBULL · day 33
Key stats
- Market cap
- $5.3B
- Beta
- -0.25
- P/E (TTM)
- 38.71
- 1W
- +0.00%
- 1M
- +0.39%
- vs SPY 1W
- -1.56%
- vs SPY 1M
- -1.37%
Industry peers
FMP comparable companies · ranked by market cap
- KNSABUYKiniksa Pharmaceuticals International, plc$5.8BBULLQ 23$76.31+1.01%
- CDTXCidara Therapeutics, Inc.$5.6B$221.38
- SRRKSELLScholar Rock Holding Corporation$5.2BCRISISQ 22$43.40+0.00%
- ADPTBUYAdaptive Biotechnologies Corporation$4.8BCRISISQ 6$29.84-0.72%
- CPRXBUYCatalyst Pharmaceuticals, Inc.$3.9BBULLQ 20$31.49+0.00%
- IDYASELLIDEAYA Biosciences, Inc.$3.6BBEARQ 25$38.06-0.55%
- BEAMSELLBeam Therapeutics Inc.$2.6BRECOVERYQ 13$25.67-0.69%
- RXRXBUYRecursion Pharmaceuticals, Inc.$2.5BCRISISQ 0$4.78-7.49%
- MLYSSELLMineralys Therapeutics, Inc.$2.1BCRISISQ 18$23.30+1.31%
- AGIOSELLAgios Pharmaceuticals, Inc.$1.9BRECOVERYQ 4$31.25+0.41%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…